DK

Divyanshu Kumar

Active Director Director DIN 09466264
DIN 09466264 First appointment Jan 2022 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value •••• Premium profile

About Divyanshu Kumar

Data last updated:

Divyanshu Kumar is a Director at Maelwine Pharmaceuticals Private Limited (since 2022). The company operates in Business Services. Maelwine Pharmaceuticals Private Limited reported revenue of ₹19 Lakh (FY 2022).

DIN 09466264
Primary Designation Director
Industry Business Services
First Appointment 03 Jan 2022
Oldest Company Age 6 yrs
Largest company Maelwine Pharmaceuticals Private Limited · ₹19 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Jan 20222020₹19 Lakh (FY 2022)Active

Board colleagues of Divyanshu Kumar

Directorship timeline

Open interactive timeline →
Maelwine Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Divyanshu Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Divyanshu Kumar

Divyanshu Kumar currently holds 1 directorship: Maelwine Pharmaceuticals Private Limited (Director, since 03 Jan 2022, revenue ₹19 Lakh (FY 2022)).

Divyanshu Kumar was first appointed on 03 Jan 2022 as Director at Maelwine Pharmaceuticals Private Limited.

The current boards of Divyanshu Kumar's companies include Manisha Sharma (Maelwine Pharmaceuticals Private Limited), Rohit Raj (Maelwine Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available